The non-cancer mortality experience of male workers at British Nuclear Fuels plc, 1946-2005
- PMID: 18319298
- PMCID: PMC2409051
- DOI: 10.1093/ije/dyn018
The non-cancer mortality experience of male workers at British Nuclear Fuels plc, 1946-2005
Abstract
Background: Recent studies of the Hiroshima and Nagasaki A-bomb survivors, together with some (but not all) cohorts exposed occupationally or medically to ionizing radiation, have found an increasing trend in mortality from non-malignant disease with increasing radiation dose. The aim of this study was to establish whether such a trend could be found in a large cohort of employees in the UK nuclear industry.
Methods: The cohort comprised 64 937 individuals ever employed at the study sites between 1946 and 2002, followed up to 2005; radiation exposures as measured by personal dosimeters ('film badges') were available for 42 426 individuals classified as 'radiation workers'. Poisson regression models were used to investigate the relationship between excess mortality rates and cumulative radiation exposure, using both relative and additive risk models.
Results: The cohort shows a pronounced 'healthy worker' effect. Overall, socio-economic status as indicated by employment status has a greater influence on mortality than does radiation exposure status. For male radiation workers, there is an apparent dose response for mortality from circulatory system disease [P < 0.001, ERR = 0.65 (90% CI 0.36-0.98) Sv(-1)]. However there is evidence for inhomogeneity in the apparent dose response (P = 0.016), arising principally at cumulative doses in excess of 300 mSv, when the four categories of employment and radiation exposure status are examined separately.
Conclusions: We have found evidence for an association between mortality from non-cancer causes of death, particularly circulatory system disease, and external exposure to ionizing radiation in this cohort. However, the tentative nature of biological mechanisms that might explain such an effect at low chronic doses and the above inhomogeneities in apparent dose-response, mean that the results of our analysis are not consistent with any simple causal interpretation. Further work is required to explain these inhomogeneities, and on the possible role of factors associated with socio-economic status and shift working, before any further conclusions can be drawn.
Figures
Comment in
-
Commentary: A dose-response relationship for radiation-induced heart disease--current issues and future prospects.Int J Epidemiol. 2008 Jun;37(3):518-23. doi: 10.1093/ije/dyn067. Epub 2008 May 1. Int J Epidemiol. 2008. PMID: 18450809 No abstract available.
-
Comments: The non-cancer mortality experience of male workers at British Nuclear Fuels plc, 1946-2005.Int J Epidemiol. 2009 Aug;38(4):1159-64. doi: 10.1093/ije/dyn122. Epub 2008 Jul 9. Int J Epidemiol. 2009. PMID: 18614611 No abstract available.
References
-
- Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res. 2003;160:381–407. - PubMed
-
- Shimizu Y, Kato H, Schull WJ, Hoel DG. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 3. Noncancer mortality based on the revised doses (DS86) Radiat Res. 1992;130:249–66. - PubMed
-
- Shimizu Y, Pierce DA, Preston DL, Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, part II. Noncancer mortality: 1950-1990. Radiat Res. 1999;152:374–89. - PubMed
-
- Shimizu Y. Life Span Study Report 11, part 3. Noncancer mortality, 1950-85, based on the revised dosimetry (DS86). Hiroshima: Radiation Effects Research Foundation; 1993. Studies of the mortality of the atomic bomb survivors.
-
- McGale P, Darby SC. Low doses of ionizing radiation and circulatory diseases: a systematic review of the published epidemiological evidence. Radiat Res. 2005;163:247–57. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
